Sort
11,323 grants matching “glioblastoma”
Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition
$413,778Robert M Prins · University Of California Los Angeles · P50 · FY2024 · CA
Nanotherapeutic treatment of the invasive glioblastoma microenvironment
$413,777Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2019 · NS
Novel regulation of beta-catenin expression in migrating astrocytes
$413,750David G Wells · Yale University · R01 · FY2009 · NS
Epigenetic regulation of temozolomide responsiveness in glioblastoma
$413,695Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2008 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
$413,689Hui Mao · Emory University · R01 · FY2018 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$413,641Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2021 · NS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
$413,481Atsuo Sasaki · University Of Cincinnati · R01 · FY2021 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$413,174Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Metabolic Control of Immune Suppression in Gliomas
$413,173Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2018 · NS
Metabolic Control of Immune Suppression in Gliomas
$413,173Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2019 · NS
TECH Core
$413,131Kevin William Eliceiri · University Of Minnesota · U54 · FY2022 · CA
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models
$413,102Joshua John Breunig · Cedars-Sinai Medical Center · R33 · FY2021 · CA
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models
$413,102Joshua John Breunig · Cedars-Sinai Medical Center · R33 · FY2020 · CA
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models
$413,100Joshua John Breunig · Cedars-Sinai Medical Center · R33 · FY2019 · CA
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$413,098Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune Microenvironment
$412,964E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2025 · NS
HTS for Identification of Novel Inhibitors of Pyk2 Activity
$412,894Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2016 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$412,847David R Plas · University Of Cincinnati · R01 · FY2023 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$412,847David R Plas · University Of Cincinnati · R01 · FY2022 · CA
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$412,828Biplab Dasgupta · Emory University · R01 · FY2024 · NS
Regulation of Neuroinflammation by Meningeal Lymphatics
$412,699Zsuzsanna Fabry · University Of Wisconsin-Madison · R01 · FY2022 · NS
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2022 · NS
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2023 · NS
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2021 · NS
Molecular mechanisms that regulate ADAR target recognition and RNA editing
$412,525Heather Ann Hundley · Trustees Of Indiana University · R35 · FY2025 · GM